Table 2.

Metabolic profile in PCOS with thyroid disease.

Participants		Metabolic profile	Ref
Study group	Control group
114 PCOS patients with SCH	253 PCOS patients without SCH	Exacerbated the metabolic disorders (insulin resistance and dyslipidemia) in PCOS patients with SCH	(35)
20 patients with PCOS and SCH	39 patients with PCOS and normal thyroid function and 53 healthy women with normal thyroid function	Dyslipidemia with higher triglyceride levels and insulin resistance in group with PCOS and subclinical hypothyroidism	(37)
148 women with PCOS, without Type 2 diabetes mellitus (T2DM) and CVD present at baseline		At baseline, prevalent prediabetes was present in 18 (12%) of PCOS cases and it progressed to T2DM in 5 (3%) of the cases. Incident prediabetes during the follow-up was noted in 47 (32%) women or 4.7 per 1000 persons/year. cardiovascular risk in PCOS women with prediabetes was high.	(38)
100 females with PCOS	100 normal controls	Significantly higher HOMA-IR and frequency of subjects with dyslipidemia in SCH PCOS subjects	(39)
583 women with PCOS		Patients with elevated TSH levels had significantly increased fasting insulin and total cholesterol (TC)/high-density lipoprotein cholesterol (HDL) ratio.	(40)